ARCHIVES

Joseph Jacobs, New Head Of alternative Medicine Office, Vows To ‘Talk Bluntly’

This article is from The Cancer Letter archive.

Vol. 18 No. 48 | December 11, 1992

Download PDF Visit The Full Archive

Related Articles

Richard Bloch’s Dream Of Empowering Patients Had Rough Beginning

October 11, 1996

Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV

October 28, 2011

NCI Director To Decide Fate Of P-4 After NCAB Meeting In June.

April 20, 2007

NCI to Suggest Changes In Cooperative Group Terms of Award At Chairman’s Meeting Next Week

November 18, 1988

Oral Complications Reduced By Pretherapy NIH Conference Finds

April 28, 1989

Major Changes In NCI Drug screening Tumor Panels Approved

June 18, 1982